Holen Sie sich die Stockscreener-App
13.26
0.37%
-2.31
Schlusskurs vom Vortag:
$10.95
Offen:
$13.55
24-Stunden-Volumen:
830
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
$614.00K
Nettoeinkommen (Verlust:
$-76.35M
KGV:
-0.2784
EPS:
-47.63
Netto-Cashflow:
$-31.51M
1W Leistung:
-0.37%
1M Leistung:
-56.83%
6M Leistung:
-76.92%
1J Leistung:
+245.37%
1-Tages-Spanne:
$13.50
$13.70
1-Wochen-Bereich:
$13.50
$13.70
52-Wochen-Spanne:
$13.50
$13.70
Finch Therapeutics Group Inc Stock (FNCH) Company Profile
Firmenname
Finch Therapeutics Group Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie FNCH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FNCH
Finch Therapeutics Group Inc
|
13.70 | 0 | 614.00K | -76.35M | -31.51M | -47.63 |
|
ONC
Beigene Ltd Adr
|
238.31 | 25.61B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.00 | 114.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.26 | 41.82M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.26 | 66.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.61 | 6.36B | 0 | -153.72M | -103.81M | -2.00 |
Finch Therapeutics Group Inc Stock (FNCH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | BofA Securities | Buy |
| 2021-04-13 | Eingeleitet | Evercore ISI | Outperform |
| 2021-04-13 | Eingeleitet | Jefferies | Buy |
Finch Therapeutics Group Inc Aktie (FNCH) Neueste Nachrichten
Fecal Transplant Treatment Market: Manufacturer Capacity, Output, Sales, Competition Analysis Report 2025 - openPR.com
Live Biotherapeutic Product Market Growth Driven by Digestive - openPR.com
Critical Review: Enfusion (NYSE:ENFN) vs. Duos Technologies Group (NASDAQ:DUOT) - Defense World
Life360 (NASDAQ:LIF) versus Workday (NASDAQ:WDAY) Head-To-Head Comparison - Defense World
Head to Head Contrast: Crimson Wine Group (OTCMKTS:CWGL) versus Eastside Distilling (NASDAQ:BLNE) - Defense World
Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World
Clostridium Difficile Infections Clinical Trials 2025: EMA, - openPR.com
Stifel Financial Corp Acquires 1,495 Shares of Iridium Communications Inc. (NASDAQ:IRDM) - Defense World
Dimensional Fund Advisors LP Has $4.56 Million Position in Red River Bancshares, Inc. (NASDAQ:RRBI) - Defense World
Microbiome Therapeutic Market Poised to Reach USD 3,121.8 Million by 2035, Growing at a CAGR of 14.2% - openPR.com
Dimensional Fund Advisors LP Has $10.38 Million Stock Position in Ero Copper Corp. (NYSE:ERO) - Defense World
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Calamos Long/Short Equity & Dynamic Income Term Trust (NASDAQ:CPZ) Short Interest Down 15.0% in April - Defense World
Clostridium Difficile Infections Pipeline and Clinical Trials - openPR.com
5 Best Microbiome Companies (May 2025) - Securities.io
Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha
Arquitos Capital Management Q1 2025 Investor Letter - Seeking Alpha
Global Human Microbiome Market: Exploring Technological Innovations Fueling 31% CAGR Growth by 2030 - PharmiWeb.com
Prosperity Bancshares (PB) Expected to Announce Quarterly Earnings on Wednesday - American Banking and Market News
Vanguard Group Inc. Increases Stake in Westrock Coffee (NASDAQ:WEST) - Defense World
Financial Contrast: Kiromic BioPharma (NASDAQ:KRBP) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World
Clostridium Difficile Infections Pipeline 2025: MOA, ROA, - openPR.com
Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market: A ... - WhaTech
Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell? - Defense World
Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Up 1.5% – Still a Buy? - Defense World
Wickes Group (LON:WIX) Trading Down 0.2% – What’s Next? - Defense World
TechBio and Microbiome (III) - substack.com
Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire
Microbiome Disease Clinical Trial Analysis: Key Insights - GlobeNewswire
(PDF) Global Human Microbiome Market: The Impact of Lifestyle Diseases on the Projected 31% CAGR Growth by 2030 - ResearchGate
Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 0.3% – What’s Next? - Defense World
Innovent Biologics (OTCMKTS:IVBXF) Shares Down 0.2% – Here’s Why - Defense World
Scheid Vineyards (OTCMKTS:SVIN) Stock Price Down 5.3% – What’s Next? - Defense World
Thunderbird Entertainment Group (OTCMKTS:THBRF) Stock Price Down 5.9% – Here’s Why - Defense World
COSCO SHIPPING (OTCMKTS:CICOF) Trading Up 9.7% – Here’s What Happened - Defense World
Clostridium Difficile Infections Clinical Trials and Pipeline - openPR
Ulcerative Colitis Clinical Trials and Drugs 2025: EMA, PDMA, - openPR
Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher - Seeking Alpha
Human Microbiome Market Size to Surge to $4.85 Billion by - GlobeNewswire
Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha
B. Riley Analysts Decrease Earnings Estimates for Magnite - Defense World
Liquidity Services (LQDT) Expected to Announce Quarterly Earnings on Thursday - Defense World
Sixth Street Specialty Lending (NYSE:TSLX) Sets New 52-Week High After Analyst Upgrade - Defense World
AptarGroup (ATR) Projected to Post Quarterly Earnings on Thursday - Defense World
Atb Cap Markets Has Bearish Outlook for TSE:KEC Q2 Earnings - Defense World
Research Analysts Set Expectations for Redwire Q2 Earnings - Defense World
Phillips Edison & Company, Inc. (PECO) Projected to Post Earnings on Thursday - Defense World
Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World
PG&E Co. (NYSE:PCG) Given Average Rating of “Moderate Buy” by Analysts - Defense World
CARGO Therapeutics, Inc. Announces Workforce Reduction and Strategic Shift - Defense World
Sumco (OTCMKTS:SUMCF) Trading Down 2% – Time to Sell? - Defense World
Finanzdaten der Finch Therapeutics Group Inc-Aktie (FNCH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.96%
Kapitalisierung:
|
Volumen (24h):